OEM Alignment The acquisition by Biosense Webster signals strong strategic interest from leading cardiology device players in advanced imaging. Sales opportunities include engaging major electrophysiology and interventional device manufacturers to explore integration or co development of NuVera’s imaging platform into existing systems and joint market access at hospitals.

Target EP Labs NuVera’s platform is aimed at complex cardiovascular procedures, aligning with high‑value electrophysiology labs and tertiary care centers seeking enhanced visualization and workflow gains. Propose pilots or clinical collaborations to demonstrate improvements in procedural efficiency, safety, and differentiation in real world settings.

Incubator Network As a Shifamed portfolio company, NuVera can tap into a broader medical device ecosystem for partnerships and distribution. Leverage portfolio connections to identify customers, pursue cross portfolio collaborations, and accelerate introductions to strategic buyers and potential channel partners.

Agile Development A small, nimble team enables rapid customization and iteration to meet hospital needs. Offer modular software add ons or configurable imaging workflows with flexible professional services and upgrade paths to sustain ongoing revenue from adoption and expansion.

Market Credibility Historical funding activity and strategic acquisition signals indicate market validation and investor interest. Pursue co development or strategic partnerships with large medtech players to accelerate regulatory clearance, geographic expansion, and faster market entry.